Human interleukin 6 and tumor necrosis factor α production studied at a single‐cell level
- 1 June 1989
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 19 (6), 1157-1160
- https://doi.org/10.1002/eji.1830190629
Abstract
Individual peripheral blood mononuclear cells, which produced interleukin 6 (IL 6) or tumor necrosis factor α, (TNF α), were studied by cytokine‐specific polyclonal or monoclonal antibodies (mAb) and immunofluorescence technique with UV microscopy. Lipopolysaccharide (LPS) induced IL 6 as well as TNF α production in the majority of the monocytes, but not at all in lymphocytes. Approximately every second monocyte made TNF α in response to LPS within 0.5 h from start of the cultures, when no IL6 or TNF α production occurred. The maximal number of TNF α‐synthesizing monocytes was observed 1.5 h later and then rapidly declined. LPS stimulation led to optimal IL 6 production 3 h after initiation of the cultures, with 90% of the monocytes expressing intracellular IL 6. LPS‐induced IL 6 synthesis started about 1 h after that of TNF α. Polyclonal T cell activation with staphylococcal enterotoxin A or anti‐CD3 mAb induced a biphasic production pattern of IL 6 as well as TNF α. Early IL 6 synthesis, which peaked 6–8 h from start of the cultures, occurred exclusively in monocytes, while late IL 6 production at 48 h was restricted to a small fraction of lymphoid cells. T cell mitogen induced early TNF α production, which peaked at 6 h, took mainly place in monocytes and to a minor degree in CD4+ as well as CD8+ T cells. The majority of the TNF α‐producing mononuclear cells at 24 h were of the CD4+ T cell lineage in the staphylococcal enterotoxin A‐ or anti‐CD3 mAb‐activated cultures. IL 6 as well as TNF α accumulated in the Golgi system, which resulted in a characteristic morphology of the staining, eliminating problems with evaluation of background signals.This publication has 18 references indexed in Scilit:
- Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunityImmunology Letters, 1988
- Evidence that Tumour Necrosis Factor (TNF) is not Constitutively Present in Vivo The Association of TNF with Freshly Isolated Monocytes Reflects a Rapid in Vitro ProductionScandinavian Journal of Immunology, 1988
- Identification of individual tumor necrosis factor/ cachectin‐producing cells after lipopolysaccharide inductionEuropean Journal of Immunology, 1988
- Comparison of patterns of expression of tumour necrosis factor, lymphotoxin and interleukin-6 MRNABiochemical and Biophysical Research Communications, 1988
- Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2‐dependent cell line and preparation of anti‐IL 6 monoclonal antibodiesEuropean Journal of Immunology, 1988
- Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.The Journal of Experimental Medicine, 1988
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Regulation of Human Gamma-Interferon and Beta-Interferon Gene Expression in PHA-Activated LymphocytesJournal of Interferon Research, 1986
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Perturbation of vesicular traffic with the carboxylic ionophore monensinCell, 1983